Specific O-GlcNAc Modification at Ser-615 Modulates Ser-1177 Phosphorylation of eNOS and Leads to Vascular Dysfunction in Pulmonary Arterial Hypertension - Bioinformatics Solutions Inc

Specific O-GlcNAc Modification at Ser-615 Modulates Ser-1177 Phosphorylation of eNOS and Leads to Vascular Dysfunction in Pulmonary Arterial Hypertension

On 2017-05-222017-07-04By Bioinformatics Solutions IncIn User Publications

Kulwant, A., et al. Specific O-GlcNAc Modification at Ser-615 Modulates Ser-1177 Phosphorylation of eNOS and Leads to Vascular Dysfunction in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 195(A4215). 22/5/2017.